David Buttar

AstraZeneca (United Kingdom) — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index1.6kcitations57works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(15), Computational Drug Discovery Methods(11), Machine Learning in Materials Science(10), Muon and positron interactions and applications(7), Cancer therapeutics and mechanisms(5)

Publications57 total

metal_ts_study
ioChem-BD Computational Chemistry Datasets·2025Open Access
Benchmark of double-ended transition state search methods for metal-catalysed reactions
2025Open Access
The Implementation and Impact of Chemical High-Throughput Experimentation at AstraZeneca
ACS Catalysis·2025· 18 cited
Correction: Distortion/interaction analysis <i>via</i> machine learning
Digital Discovery·2025Open Access
Distortion/Interaction Analysis via Machine Learning
2024Open Access
An Intramolecular Diels–Alder Approach to the Isoindolinone Core of AZD8154
Organic Process Research & Development·2024· 5 cited
Distortion/interaction analysis <i>via</i> machine learning
Digital Discovery·2024· 3 citedOpen Access
Supplementary Methods from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Data from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Figure Legends from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Methods from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Figure Legends from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Tables and Legends from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Figures from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Tables and Legends from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Data from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Supplementary Figures from AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and &lt;i&gt;ESR1&lt;/i&gt;-Mutant Breast Tumors in Preclinical Models
2023Open Access
Machine learning reaction barriers in low data regimes: a horizontal and diagonal transfer learning approach
Digital Discovery·2023· 23 citedOpen Access
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology
Journal of Medicinal Chemistry·2022· 53 citedOpen Access
The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine Dendrimer
Journal of Pharmaceutical Sciences·2022· 8 cited
page 1 of 3Next →

Frequent Co-authors

Peter Ballard(12), Jon Curwen(12), Craig S. Donald(11), Richard A. Norman(11), Stuart E. Pearson(10), Hazel M. Weir(10), Robert H. Bradbury(10), Alfred A. Rabow(10), Philip A. MacFaul(10), Michael Tonge(10), Graeme E. Walker(10), Zena Wilson(10), Chris De Savi(10), Mandy Lawson(9), Rowena Callis(9), Steve Powell(9), Graham H.P. Richmond(9), Celina M. D’Cruz(9), Galith Karoutchi(8), Rachel Rowlinson(8)